Results summary | View all lists in L2L MDB | View all genes in R05DB.profile.ud50 |
Upregulated in VHL-null renal carcinoma vs. normal renal cells (Fig. 2c+e) enrichment: 1.88-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
201016_AT | EIF1AX | P | eukaryotic translation initiation factor 1A, X-linked | ||||||||||
209434_S_AT | PPAT | phosphoribosyl pyrophosphate amidotransferase | |||||||||||
209135_AT | ASPH | P | aspartate beta-hydroxylase | ||||||||||
208673_S_AT | SFRS3 | R | splicing factor, arginine/serine-rich 3 | ||||||||||
209214_S_AT | EWSR1 | R | Ewing sarcoma breakpoint region 1 | ||||||||||
201167_X_AT | ARHGDIA | G | C | S | Rho GDP dissociation inhibitor (GDI) alpha | ||||||||
211527_X_AT | VEGFA | G | D | X | S | vascular endothelial growth factor A |